Summers Value Partners Q4 2025 Partner Letter [Seeking Alpha]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Seeking Alpha
The healthcare sector faced significant pressure following the inauguration of the new administration in January. The Fund's allocation to pharmaceutical and biotechnology stocks increased significantly during the year to over 40% by year end. mohd izzuan/iStock via Getty Images Dear Fellow Partners: The Summers Value Fund LP (“the Fund”) returned 6.7% net in 2025, trailing the Russell 2000 Index ETF ( IWM ), which returned 12.7%, and the Russell 2000 Value Index ETF ( IWN ), which returned 12.4%. While our performance in 2025 fell short of expectations, the Fund's long-term performance remains strong. Since inception, the Fund has delivered a 12.0% annualized net return compared to 6.9% for IWM and 6.3% for IWN. Trailing Period Returns Summers Russell 2000 Russell 2000 Value Fund LP Small-Cap Index Value Index 1 Year 3 Years 5 Years Cumulative Since Inception Annualized Since Inception Click to enlarge Fund Commentary In the first half of the ye
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Merck: Bullish Setup Into Q1 Earnings [Seeking Alpha]Seeking Alpha
- Sun Pharma to acquire Organon in $11.75 billion deal [Yahoo! Finance]Yahoo! Finance
- Sun Pharma to acquire Organon for $11.75bn [Yahoo! Finance]Yahoo! Finance
- Merck Advances Terns Deal And Cardiovascular And RSV Growth Options [Yahoo! Finance]Yahoo! Finance
- Merck & Co. Inc. (MRK): One of the Best Low Risk High Growth Stocks to Buy Right Now [Yahoo! Finance]Yahoo! Finance
MRK
Earnings
- 2/3/26 - Beat
MRK
Sec Filings
- 4/8/26 - Form ARS
- 4/8/26 - Form DEFA14A
- 4/8/26 - Form DEF
- MRK's page on the SEC website